Adaptive Biotechnologies Corpor - stock earnings
ADPT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -69.4 million USD | 45.8 million USD |
| 2023Q3 | -50.3 million USD | 37.9 million USD |
| 2023Q2 | -47.8 million USD | 48.9 million USD |
| 2023Q1 | -61.7 million USD | 37.6 million USD |
| 2022Q4 | -24.5 million USD | 55.2 million USD |
| 2022Q3 | -45.2 million USD | 47.8 million USD |
| 2022Q2 | -51.6 million USD | 43.7 million USD |
| 2022Q1 | -62.5 million USD | 38.6 million USD |
| 2021Q4 | -61.4 million USD | 37.9 million USD |
| 2021Q3 | -56.0 million USD | 39.5 million USD |
| 2021Q2 | -49.3 million USD | 38.5 million USD |
| 2021Q1 | -40.6 million USD | 38.4 million USD |
| 2020Q4 | -44.6 million USD | 30.2 million USD |
| 2020Q3 | -36.7 million USD | 26.3 million USD |
| 2020Q2 | -33.5 million USD | 21.0 million USD |
| 2020Q1 | -31.4 million USD | 20.9 million USD |
| 2019Q4 | -20.6 million USD | 24.2 million USD |
| 2019Q3 | -14.0 million USD | 26.1 million USD |
| 2019Q2 | -15.7 million USD | 22.1 million USD |
| 2019Q1 | -18.4 million USD | 12.7 million USD |
| 2018Q4 | -13.3 million USD | 17.2 million USD |
| 2018Q3 | -8.3 million USD | 17.2 million USD |
| 2018Q2 | -12.5 million USD | 11.6 million USD |
| 2018Q1 | -12.4 million USD | 9.7 million USD |
ADPT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -225.3 million USD | 170.3 million USD |
| 2022 | -142.5 million USD | 185.3 million USD |
| 2021 | -205.6 million USD | 154.3 million USD |
| 2020 | -139.6 million USD | 98.4 million USD |
| 2019 | -58.8 million USD | 85.1 million USD |
| 2018 | -46.4 million USD | 55.7 million USD |
| 2017 | -42.8 million USD | 38.4 million USD |
ADPT
Price: $2.93
52 week price:
Earnings Per Share: -1.56 USD
P/E Ratio: -2.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Market Capitalization: 422.2 million